Lietao LI, Victor
Founding CEO
About
Dr. Li builds ventures that translate scientific ideas into first-in-class immunotherapy clinical assets and has led the BioIP Group since 2021. Previously, as Founding CEO, he led the development of PIKA adjuvant vaccines and TCR/CAR-T cell therapies for viral infections and related cancers. Multiple lead assets have since progressed to Phase II and Phase III clinical trials.
Singapore
Singapore
Biotechnology
Biotechnology, Technology Transfer
Experience

Founding CEO
BioIP Group
Singapore, Munich, China
BioIP Holdings is a biotechnology intellectual property holding group developing first-in-class immunotherapies through its wholly owned subsidiaries, Eximmium and Zeno Therapeutics.

Founder & Director Singapore Biotech Affiliates
Lion TCR, SCG Cell Therapy, Biosyngen, BioCheetah
Singapore & China
Clinical-stage biotech ventures focused on first-in-class cell therapies for virus-related cancers and viral infections, and IVD

Founder & Director
NewBiomed PIKA Pte. Ltd (acquired, Nasdaq: YS)
Singapore
Clinical-stage biotech developing the PIKA adjuvant and vaccines; the lead PIKA-adjuvanted rabies vaccine completed Phase II clinical trials.
Lietao LI, Victor's Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles

Find Emails
Access verified email addresses for your target contacts.
657M+ emails

Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers

More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.





